Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-77 in Recurrent Platinum-Sensitive Ovarian Cancer
NCT00004083Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Feb 1999
- Primary completion
- Dec 1999
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in ovarian cancer, sponsored by NYU Langone Health. Started Feb 1999; status: completed.
02
Drugs
cisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00004083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004083.